About Aralez

The combination of POZEN and Tribute Pharmaceuticals represents an important strategic transformation that created Aralez Pharmaceuticals, a specialty pharmaceutical company with a compelling growth platform.

Our Portfolio

The Aralez portfolio of approved products is anchored in cardiovascular disease and plans for continued development and growth in this and other specialty areas.

For Investors

Aralez is focused on delivering meaningful products to improve patients’ lives while growing shareholder value in short, medium and long-term. Investor information such as press releases, presentations and webcasts can be found in this section.